OraSure Technologies.
medical device company
- Reports this week
- 0
- Active events
- 0
- Connections
- 28
What's happening
Earlier this month
One to three months ago
Gone quiet
No new reports in 90+ days-
Sherlock Biosciences and DNA Genotek Inc. are now wholly-owned subsidiaries of OTI.Some support2 reports
-
OraSure Technologies established a new relationship with Targeted Genomics and renewed an agreement with gene Dx on August 6, 2025.Some support1 report
-
David Nierenberg made portfolio updates on August 12, 2025, including increased stakes in Lyft, OraSure Technologies, Criteo SA, and Green Dot Corp.Some support1 report
-
OraSure Technologies operates within the U.S. stock market, and there is M&A interest from Ron Zwanziger.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around OraSure Technologies this week
News at the entities that move OraSure Technologies most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves OraSure Technologies
-
MarketBeat Mentioned togetherApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves OraSure Technologies
-
Uganda OperationalAllegations of border issues involving election materials are reported between Uganda and Kenya.Moves OraSure Technologies
-
Hoffmann-La Roche StructuralNvidia and Hoffmann-La Roche share interest in AI-driven therapeutics following the establishment of a new innovation center in Boston.Moves OraSure Technologies
-
Democratic Republic of the Congo Shared contextRecent health center attacks occurred near Butembo in the Democratic Republic of the Congo.Moves OraSure Technologies
-
Nasdaq StructuralAppLovin stock is traded on Nasdaq, and both AppLovin and Trade Desk operate in the competitive digital advertising technology landscape.Moves OraSure Technologies
Connections
The 8 strongest of 28, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Ken McGrath Structural
OraSure appointed Ken McGrath to the role of Chief Financial Officer (CFO).
-
FDA Structural
FDA granted Emergency Use Authorization to OraSure Technologies.
-
Scott Gleason Structural
Scott Gleason served as interim CFO for OraSure Technologies during its scaling phase.
-
Nasdaq Structural
OraSure Technologies is listed on the Nasdaq stock exchange.
-
Hoffmann-La Roche Structural
OraSure supplies testing kits that are utilized by Hoffmann-La Roche for its procedures.
-
Uganda Operational
OraSure Technologies' testing capabilities are being utilized to support containment efforts during an outbreak in Uganda.
-
MarketBeat Mentioned together
MarketBeat provides consensus ratings and financial analysis for OraSure Technologies.
-
Democratic Republic of the Congo Shared context
OraSure Technologies operates within the context of containment efforts during an outbreak in the Democratic Republic of the Congo.
History
Events by the month they beganSeptember 2026
1 eventAugust 2026
2 eventsJune 2026
4 events- Sherlock Biosciences and DNA Genotek Inc. are now wholly-owned subsidiaries of OTI.
- OraSure Technologies established a new relationship with Targeted Genomics and renewed an agreement with gene Dx on August 6, 2025.
- David Nierenberg made portfolio updates on August 12, 2025, including increased stakes in Lyft, OraSure Technologies, Criteo SA, and Green Dot Corp.
- OraSure Technologies operates within the U.S. stock market, and there is M&A interest from Ron Zwanziger.